Featuring news, events and industry trends
Oligomerix Announces Late-Breaking Presentation at 2021 Clinical Trials on Alzheimer's Disease (CTAD) Conference
White Plains-based Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, announced that the Company will deliver a virtual oral presentation at the 14th Annual Clinical Trials on Alzheimer's Disease (CTAD) conference, being held in Boston on November 9-12, 2021.
New Research Published in Nutrients on Nutrition21's Esports Nootropic Ingredient, nooLVL®

Harrison-based Nutrition21 announced new research on the cognitive benefits of nooLVL, a patented complex of Bonded Arginine Silicate with an additional optimized dose of Inositol, has been published in Nutrients. The study, performed at Texas A&M University, demonstrated that nooLVL significantly increases cognitive performance in gamers after a single dose and within 15 minutes.
The new data supports prior research on nooLVL for improving cognitive benefits for esports gamers, who rely on quick reactions, focus, memory, and fine motor skills to excel during competition, skills that are especially important when they are facing off against each other in high stakes tournaments and events.
Dr. Raj Ratan, Chief Executive Officer of Burke Neurological Institute, Gave Vision Talk at Recent New York Bio Conference

The Westchester County Office of Economic Development sponsored a Vision Talk at New York Bio’s 2021 Annual Meeting featuring special guest speaker Dr. Raj Ratan of the Burke Neurological Institute at Weill Cornell. To learn more about some of the exciting things happening in Westchester's biosciences ecosystem, and to hear Dr. Ratan's presentation "A Novel Strategy to Cure Neurological Disability Into the 22nd Century", click here. 
Crossing the Valley of Death: Lab to IPO and Lab to Acquisition, November 30 at 1 PM

On November 30th hear from Josep Bassaganya-Riera, Chairman and CEO Landos BioPharma, and Matthew Meyer, former Chief Business officer CAREDx and now Chief Buisness Advisor Wilson Sonsini, as they share their journey crossing the chasm to lead ventures from academia to the public market.

Immediately following the Q&A portion of the panel, you'll have an opportunity to meet and talk with the speakers at virtual tables.

Date: November 30, 2021
Time: 1:00 PM – 2:30 PM
Start at the End: Thinking Commercial during Discovery and Development

When your product launches 5, 8 or 10 years from now, what do you intend the label to read? You cannot make any commercial claim if it is not scientifically proven and written in the label. As early as discovery and throughout development, entrepreneurs and startups would do well to keep their end-goal in mind.

What is the exact target population, indication and formulation? Which benefits, risks and tolerability concerns are acceptable? What are unique selling points compared to competitors? And who is going to pay?

During this session, hosted by Johnson and Johnson, speakers discuss their views on the importance of ascertaining early how health interventions will potentially add value in the future marketplace. Developers need to consider all the stakeholders — Patients, Partners, Prescribers and Payers. Having a clear picture could help guide business decisions and business development opportunities.

Please note: This is the recording of a webinar which took place on October 28, 2021. Tune into the replay here.

Have good news to share from
Westchester’s biosciences ecosystem?

Please let us know.

If you would like to continue receiving this weekly newsletter,
please sign up below. If you would like to contact us directly, click the Contact Us link.